Cordio Medical Pushes Speech Processing to Monitor Heart Failure
Cordio Medical, a provider of solutions for monitoring health conditions through patients' speech, has raised $18 million from Ceros Financial Services and Peregrine Ventures to advance its technologies and expand globally.
Cordio Medical's HearO product converts smartphones into medical-grade devices with an app that can monitor and detect fluid accumulation related to congestive heart failure. It collects a speech sample from the patient's mobile device, analyzes the results, and if a problem is detected, a healthcare professional immediately notifies the patient with an alert.
"More than 5.7 million Americans are afflicted with congestive heart failure (CHF), making it one of the most prevalent and costly conditions in the U.S.," said Tamir Tal, CEO of Cordio Medical, in a statement. "This latest round of funding will allow Cordio Medical to be at the forefront of the medtech space as the definitive pioneer in leveraging speech processing technologies to monitor CHF. A smartphone running our app for remote monitoring of CHF status will improve patient mortality, quality of life, and contribute to health economic outcomes."